Terms: = Breast cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Prognosis
16 results:
1. Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis.
Zheng S; Guo G; Yang Z; Lu Y; Lu K; Fu W; Huang Q
Environ Toxicol; 2024 May; 39(5):2948-2960. PubMed ID: 38308456
[TBL] [Abstract] [Full Text] [Related]
2. Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer.
Zhang X; Feng R; Guo J; Pan L; Yao Y; Gao J
BMC Med Genomics; 2023 Nov; 16(1):300. PubMed ID: 37996875
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic analyses of genes associated with anoikis in breast cancer.
Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
PeerJ; 2023; 11():e15475. PubMed ID: 37842046
[TBL] [Abstract] [Full Text] [Related]
4. Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.
Ye Y; Luo Y; Guo T; Zhang C; Sun Y; Xu A; Ji L; Ou J; Wu SY
Front Endocrinol (Lausanne); 2023; 14():1179050. PubMed ID: 37600707
[TBL] [Abstract] [Full Text] [Related]
5. Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.
Xie J; Chen L; Wu D; Liu S; Pei S; Tang Q; Wang Y; Ou M; Zhu Z; Ruan S; Wang M; Shi J
Aging (Albany NY); 2023 Jun; 15(12):5592-5610. PubMed ID: 37338518
[TBL] [Abstract] [Full Text] [Related]
6. TGFβ Governs the Pleiotropic Activity of ndrg1 in Triple-Negative breast cancer Progression.
López-Tejada A; Griñán-Lisón C; González-González A; Cara FE; Luque RJ; Rosa-Garrido C; Blaya-Cánovas JL; Navarro-Ocón A; Valenzuela-Torres M; Parra-López M; Calahorra J; Blancas I; Marchal JA; Granados-Principal S
Int J Biol Sci; 2023; 19(1):204-224. PubMed ID: 36594086
[TBL] [Abstract] [Full Text] [Related]
7. Regulatory mechanisms and function of hypoxia-induced long noncoding RNA ndrg1-OT1 in breast cancer cells.
Chao HH; Luo JL; Hsu MH; Chen LH; Lu TP; Tsai MH; Chuang EY; Chuang LL; Lai LC
Cell Death Dis; 2022 Sep; 13(9):807. PubMed ID: 36127332
[TBL] [Abstract] [Full Text] [Related]
8. Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration.
Zhao M; Pan B; He Y; Niu B; Gao X
Aging (Albany NY); 2022 Jul; 14(14):5812-5837. PubMed ID: 35859293
[TBL] [Abstract] [Full Text] [Related]
9. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
[TBL] [Abstract] [Full Text] [Related]
10. Up-regulation of the kinase gene
Godbole M; Togar T; Patel K; Dharavath B; Yadav N; Janjuha S; Gardi N; Tiwary K; Terwadkar P; Desai S; Prasad R; Dhamne H; Karve K; Salunkhe S; Kawle D; Chandrani P; Dutt S; Gupta S; Badwe RA; Dutt A
J Biol Chem; 2018 Dec; 293(50):19263-19276. PubMed ID: 30337371
[TBL] [Abstract] [Full Text] [Related]
11. ndrg1 regulates neutral lipid metabolism in breast cancer cells.
Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS
Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756
[TBL] [Abstract] [Full Text] [Related]
12. Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-ndrg1 Axis.
Verma N; Müller AK; Kothari C; Panayotopoulou E; Kedan A; Selitrennik M; Mills GB; Nguyen LK; Shin S; Karn T; Holtrich U; Lev S
Cancer Res; 2017 Jan; 77(1):86-99. PubMed ID: 27793840
[TBL] [Abstract] [Full Text] [Related]
13. Aryl Hydrocarbon Receptor Activates ndrg1 Transcription under Hypoxia in breast cancer Cells.
Li EY; Huang WY; Chang YC; Tsai MH; Chuang EY; Kuok QY; Bai ST; Chao LY; Sher YP; Lai LC
Sci Rep; 2016 Feb; 6():20808. PubMed ID: 26852918
[TBL] [Abstract] [Full Text] [Related]
14. Aberrant ndrg1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of ndrg1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract] [Full Text] [Related]
16. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells.
Mackay A; Jones C; Dexter T; Silva RL; Bulmer K; Jones A; Simpson P; Harris RA; Jat PS; Neville AM; Reis LF; Lakhani SR; O'Hare MJ
Oncogene; 2003 May; 22(17):2680-8. PubMed ID: 12730682
[TBL] [Abstract] [Full Text] [Related]
